Probiotics Are Not All the Same: Why Strain Specificity Matters

Two probiotic products can contain the same bacterial species but still offer different benefits. Have you ever wondered why?

A label may list names such as Lactobacillus rhamnosus, Bifidobacterium lactis, or Lactobacillus acidophilus. So we assume that products containing the same species will work in the same way.

But that’s not the reality.

And the reason behind this lies in the strain. Different strains within the same species can have different properties. They can work in different ways and may support different health goals.

This blog is aimed at helping you understand why strain specificity is important when choosing or formulating a probiotic. Let’s dive into the basics first.

What Are Probiotics?

Probiotics are simply defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. This definition is given by FAO and WHO.

To simplify, there are two important things to understand. First, probiotics are living microorganisms. Second, not every microorganism associated with health is automatically considered a probiotic. There needs to be evidence that the specific microorganism provides a health benefit when consumed in an appropriate amount.

Probiotics are studied for a range of applications. These include digestive support, immune modulation, and skin health through the gut-skin axis. However, there is one important point to remember. The benefits of a probiotic are not generic. They depend on the specific strain. The International Scientific Association for Probiotics and Prebiotics (ISAPP) also states that the benefits of probiotics are strain-specific and cannot be generalized to other strains.

To understand probiotics properly, we need to look beyond the species name.

The Naming System:

Genus → Species → Strain

Probiotic bacteria are identified at different levels. Think of this as an address system with three levels.

1. Genus: The Broad Category

The genus is the broadest grouping. You can think of it as a family name.

Examples include Lactobacillus and Bifidobacterium. Lactobacillus has recently been reclassified into several new genera, although the familiar name is still commonly used on many labels.

2. Species: The Specific Group

Within each genus, there are multiple species. If the genus is like a family name, the species gives us a more specific identity.

For example, Lactobacillus rhamnosus is a species within the Lactobacillus group.

But the species name still does not tell us the complete story. For that, we need to go one step further.

3. Strain: The Precise Variation

This is where the real precision lies. A strain is a specific variation within a species. It is usually identified by a code or registered name.

For example: Lactobacillus rhamnosus GG and Bacillus coagulans SNZ 1969

The letters or numbers at the end are important. They identify the specific strain. These are not simply different ways of writing the same organism. Each strain can have its own genetic and biological characteristics.

The NIH Office of Dietary Supplements also notes that probiotics are identified by their genus, species, and strain designation. This is why the full name matters. Knowing only the species is like knowing someone’s surname without knowing exactly which person you are referring to.

Why Does Strain Specificity Matter?

Now we come back to the original question.

Why can two probiotics from the same species provide different benefits?

Because different strains can behave differently.

Different Strains Can Work in Different Ways

Research has shown that strains within the same species can differ significantly in their properties. For example, one strain of L. rhamnosus may adhere strongly to intestinal cells. Another strain from the same species may show moderate or very little adhesion.

The differences do not stop there.

Different strains may produce different metabolites. They may interact with the body in different ways. They can also influence the immune system through different mechanisms. So, the species name alone does not tell you exactly what a probiotic can do. The strain gives us a much clearer picture.

Same Species, Different Clinical Benefits

A good example comes from Lactobacillus rhamnosus.

The well-known LGG® strain, also written as L. rhamnosus GG, has been extensively studied for gastrointestinal and immune system support. It has been the subject of over 300 clinical trials. Systematic reviews have also found that it may help reduce the duration of acute infectious diarrhea in children.

Now consider another strain from the same species: Lactobacillus rhamnosus GR-1®. This strain is associated with different applications, particularly women’s urogenital health.

Both belong to the same species. But they are different strains.

That means you cannot assume that any product containing L. rhamnosus will provide the same benefits as LGG® or GR-1®. This is the key dilemma that strain specificity helps solve.

The species tells you the group. The strain tells you the specific variation that has been studied.

Clinical Evidence Cannot Be Generalized

Clinical evidence is one of the most important things to understand about probiotics. Evidence for one strain cannot automatically be applied to another strain, even if both belong to the same species.

For example, a strain studied for antibiotic-associated diarrhea may not have demonstrated the same benefit for irritable bowel syndrome. The reverse can also be true. This is why broad statements such as “probiotics work for condition X” can be misleading.

The more useful question is: Has this specific strain, at this specific dose, been studied for this specific health application?

That is where the evidence matters.

What This Means for Research

Sometimes, a clinical study evaluates a multi-strain probiotic blend and does not show the expected benefit. This does not mean that every species in the blend is ineffective. It only means that the specific combination, dose, and formulation studied did not demonstrate an effect in that particular trial.

A different strain from the same species may produce different results. This is also why it is important not to make broad conclusions such as “probiotics do not work for condition X”.

The answer depends on the details.

Which strain was studied? What dose was used? What was the intended health application? How was the probiotic formulated?

These details can make a difference.

For a nutraceutical company in India developing probiotic formulations, understanding these differences can support a more evidence-based approach to ingredient and strain selection.

Putting It Into Practice: What to Look For

So, how can this information be applied when choosing or formulating a probiotic?

Look Beyond the Species

Do not rely only on a label that says Lactobacillus acidophilus or Bifidobacterium. These names provide only part of the information. Look for the strain designation. This is usually the letters or numbers that follow the species name. That designation helps identify the specific microorganism that has been studied.

Check the Evidence

Look for strains that have been studied for the intended health application. The evidence should relate to the specific strain in the product, not simply to the genus or species. For example, evidence for one strain of Lactobacillus plantarum does not automatically apply to every other strain of the same species.

Dose Matters Too

Having the right strain is only one part of the equation. The dose also matters. Some probiotic strains may demonstrate benefits at relatively low CFU counts. Others may require higher quantities. The formulated dose should be aligned with the dose used in research supporting the intended benefit.

Consider the Health Goal

Different strains are suited to different applications. A strain studied for digestive support during antibiotic therapy may not be the right choice for immune support or women’s health. The strain should match the intended health goal.

Strain Selection Is a Strategic Decision

Brands are increasingly moving beyond broad probiotic claims. There is a growing focus on clinically backed and strain-specific ingredients. This allows formulations to be built around clearer scientific evidence and targeted applications.

For a nutraceutical company in India, strain selection is therefore more than an ingredient choice. It is an important part of developing a formulation with a clear scientific rationale. Consumers and businesses increasingly want to know what is actually present in a product and what evidence supports it. Documented strains with benefit-specific research can provide greater clarity than broad or generic probiotic claims.

As the market continues to evolve, the best nutraceutical company in India will increasingly be expected to focus on scientific validation, ingredient transparency, and evidence that supports the intended application.

The Bottom Line

Probiotics can be a valuable tool for supporting health. But they are not all the same. Two products may contain bacteria from the same species and still deliver different outcomes. The reason is the strain. Think of the species as a broad group and the strain as the specific variation within that group. The specific strain can have its own properties, mechanisms, and clinical evidence.

That is why a science-first approach matters.

FAQs